AbbVie to Present Data Across its Robust Neuroscience Portfolio at the 2021 American Academy of Neurology Annual Meeting Biotech Investing
Cardiol’s Pending Phase II/III COVID-19 Trial Medically Justified and Even More Timely Life Science Investing
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
DEADLINE ALERT for XL, PLUG, NEPT, BLU: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders Biotech Investing
NeuroRx Announces Zyesami Has Been Selected for Inclusion in NIH-Sponsored Global Clinical Trial to Include Aviptadil and Remdesivir Biotech Investing
AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Moderate to Severe Atopic Dermatitis Biotech Investing
